Loading company…
Weijiu Biotechnology researches cell therapies for age-related diseases associated with inflammation and tissue fibrosis.
Founded in 2021 and based in Suzhou, China, Weijiu Biotechnology develops therapies for age-related debilitating diseases caused by inflammation and tissue fibrosis. The company was founded by 5Y Capital and Dr. Hongjian Zhang. Following funding in 2022, it planned to build its development team and technology platform.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in